Exon Genetic & Biotechnology Engages Uganda’s Leadership on New Investments Exon Genetic & Biotechnology and BEYLER GROUP have maintained a strong interest in Uganda as part of their wider healthcare and investment activities in East Africa. On May 25, 2022, Uganda President H.E. Yoweri Kaguta Museveni received BEYLER GROUP Chairman
Strengthening Healthcare and Investment Cooperation in Uganda Exon Genetic & Biotechnology has maintained an active interest in Uganda as part of its wider African healthcare and investment strategy. In a February 2020 report, the company described a Uganda business trip organized by BEYLER GROUP in which companies from Türkiye participated.
Strengthening Türkiye–Uganda Relations Through High-Level Engagement Exon Genetic & Biotechnology recognizes the importance of strong international relationships in supporting cooperation, investment and the exchange of expertise between countries. On September 14, 2022, Exon reported on the visit of a high-level Turkish parliamentary delegation to Uganda. The delegation travelled to Uganda
